Dhampur Bio Organics Ltd · NSE:DBOL
Dhampur Bio Organics — Q2 FY2027 Earnings Presentation
21 slides from Dhampur Bio Organics's earnings presentation, November 2026
Slide 1: Dhampur Bio Organics Limited Q2FY27 Results Presentation
Dhampur Bio Organics Limited A leading integrated sugarcane processing company in India Q2FY27 Results Presentation 1
Slide 2: Safe Harbour Statement
Safe Harbour Statement This presentation is strictly confidential and may not be copied, published, distributed or transmitted. The information in this presentation is being provided by Dhampur Bio Organics Limited (also referred to as the ‘Company’). By attending the meeting where this presentation
Slide 3: Company Overview
oo e ee e© e e eo 0 © © © eo oe 0 © © © oe eo © © © © ew Company Overview 2 Oar 8) ge kek a7 hye Ot Bi lfex oe YL. ve oX 4e_ De ‘Kem oe
Slide 4: Company at a Glance
Company at a Glance Business Overview Dhampur Bio Organics Limited (DBO) is a leading cane processing company with experience and pedigree extending across 9 decades. Utilising its advanced and integrated manufacturing setups, DBO capitalises on the favourable trends in the sugar and broader agricul
Slide 5: Our Capacities
Our Capacities Uttar Uttar Mansurpur Plant Pradesh Pradesh Asmoli Plant (District Pradesh Capacity (District Sambhal) Muzaffarnagar) Total Capacity Sugar Sugarcane Crushing (TCD) 12,500 8,000 20,500 Sugar Refinery (TPD) 1,100 900 2,000 Pharma Grade Sugar (TPD) 700 - 700 Biofuel & Spirits Biofuel & S
Slide 6: Strong Leadership Team
Strong Leadership Team Gautam Goel, Ashwani Kumar Gupta, Kishor Shah, Chairman & CEO Vice Chairman & Independent Non-Executive Independent Director Director The promoter of the undivided company and Kishor is a CA with domain expertise in the was on the Board since 1994. He was sugarcane processing
Slide 7: Financial & Operational Highlights | Q2 FY27
Financial & Operational Highlights | Q2 FY27 (Standalone Financials) 7
Slide 8: Q2FY27 Performance Highlights
Q2FY27 | Performance Highlights Sugar Revenue (Net of Excise)* ₹ 665.52 Crores 12.70% Revenue Increase 23.86% (YoY) (YoY) EBITDA* Bio-Fuel & Spirits ₹ 60.04 Crores Financial Segmental 9.30% Margin (Q2FY27) (Q2FY27) Revenue Increase 9% (YoY) PAT* Country Liquor ₹ 26.62 Crores 47.73% Margin Revenue In
Slide 9: Key Financial – Q2FY27
Key Financial – Q2FY27 (₹ In Crores) Revenue from Operations EBITDA & EBITDA Margin (%) PAT & PAT Margin (%) 2.41% 9.02% 2.48% 5.93% (2.89)% 4% (3.26)% 5.33% 1220.4 400.00 500.00 1068.9 350.00 450.00 300.00 400.00 250.00 350.00 665.5 200.00 300.00 537.3 150.00 250.00 200.00 100.00 65.02 150.00 50.00
Slide 10: Profit & Loss Statement – Q2FY27
Profit & Loss Statement – Q2FY27 (₹ In Crores) Particulars Q2 FY2027 Q2 FY2026 % Change H1 FY2027 H1 FY2026 YoY Revenue( Net of Excise) at ₹ 665.5 Crores in Q2 Revenue (Net of Excise) 665.5 537.3 24% 1,220.4 1,068.9 14% FY27 as against ₹ 537.3 Crores in Q2FY26 EBITDA 60.0 13.0 364% 72.3 26.5 173% EB
Slide 11: Segmental Performance Q2FY27
Segmental Performance Q2FY27 (Standalone Financials) 11
Slide 12: Segment Highlights – Q2FY27
Segment Highlights – Q2FY27 Revenue (net of excise) (₹ In Crores) & EBIT Margin (%) Sugar Biofuel & Spirits Country Liquor 2.31% 10.15% 1.78% 6.08% -4.64% 5.32% -1.7% 6.57% 11.80% 3.37% 15.73% 3.35% 1,200.00 1,000.00 900.00 900.00 860.98 871.17 1,000.00 800.00 800.00 700.00 800.00 700.00 600.00 600.
Slide 13: Segment Overview – Q2FY27
Segment Overview – Q2FY27 Segment Performance (₹ In Crores) Particulars (₹ in Crores) Q2FY27 Q2FY26 YoY H1 FY27 H1 FY26 YoY Sugar Revenue 468.7 415.9 12.7% 861.0 871.2 (1.2%) EBIT 47.6 9.6 395.1% 52.3 15.5 236.8% EBIT Margin (%) 10.15% 2.31% 784 bps 6.08% 1.78% 429 bps Biofuel & Spirits Revenue 104.
Slide 14: Operational Performance – Q2 FY27
Operational Performance – Q2 FY27 Particulars UOM Q2FY27 Q2FY26 H1 FY27 H1 FY26 Sugar Sugar Production Tons - - 9,097 22,117 Sugar Sales Tons 96,889 96,220 1,95,914 1,91,775 Avg. Realisation ₹/Ton 48,999 40,862 45,665 40,809 Inventory* Tons 36,147 56,201 36,147 56,201 Valuation Rate * ₹/Ton 39,621 3
Slide 15: Balance Sheet Highlights
Balance Sheet Highlights (₹ In Crores) Long Term Loans Net Working Capital Long Term Debt : Equity Ratio ₹111 Crores ₹69 Crores 0.10 times as on September 30, 2026 as on September 30, 2026 as on September 30, 2026 ₹286 Crores ₹837 Crores 0.29 times as on September 30, 2025 as on September 30, 2025 a
Slide 16: Balanced Growth for a Sustainable Tomorrow
Balanced Growth for a Sustainable Tomorrow Summary of ESG content 16
Slide 17: Our ESG Strategy Construct
Our ESG Strategy Construct The Company conducted a materiality assessment to identify sustainability issues that are important to both the company and its stakeholders. This assessment involved identifying potential issues, engaging with stakeholders to understand their perspectives, and prioritizin
Slide 18: Our Contribution to UN SDGs
Our Contribution to UN SDGs Our material topics align with the following Sustainable Development Goals set forth by United Nations (UN SDGs) Responsible Governance People First Organisational ethics, values and Diversity and Inclusion governance Training and Development IT and Cybersecurity Health,
Slide 19: Our Certifications
Our Certifications Certificate of Drug Formulation Approval ISO 9001:2015 Dhampur Bio Organics Limited, Unit-Asmoli Division Sugar has been Dhampur Bio Organics Limited, Unit-Mansurpur has been certified with granted license(s) to manufacture Pharmaceutical Grade Sugar Quality ISO 9001:2015 for manu
Slide 20: Shareholders Information
Shareholders Information Individual Shareholder Information Shareholders as on 30th Sep 2026 36.01% BSE Ticker 543593 Others* 9.04% NSE Symbol DBOL Market Cap (in Rs. Crores) 837.15 NRI 3.40% % Free- float 49.00% FII Free Float Market Cap (in Rs. Crores) 400.42 0.55% Shares Outstanding (Crores) 6.64
Slide 21: Thank You
Thank You Dhampur Bio Organics Limited Email: investors@dhampur.com Contact No. : 011-6905 5200 Corp. Office: Second Floor, Plot No. 201, Okhla Industrial Estate, Phase III, New Delhi - 110 020, India Website: www.dhampur.com
Dhampur Bio Organics — Q2 FY2027 Earnings Presentation on 6ix